Metadonhydroklorid Pharmadone (Methadone Hydrochloride)

Methadone Hydrochloride is an opioid agonist used in the management of opioid dependence and chronic pain.

• Opioid dependence: reduces withdrawal symptoms and cravings during maintenance therapy.
• Chronic pain: provides long‑acting analgesia for severe, persistent pain.
• Detoxification: facilitates medically supervised opioid withdrawal in controlled settings.

• Methadone Hydrochloride acts as a full agonist at the mu‑opioid receptors in the central nervous system, producing analgesia and suppressing opioid cravings. It also blocks NMDA receptors and inhibits the reuptake of serotonin and norepinephrine, contributing to its efficacy in pain control and withdrawal management.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sleepiness or fatigue.
• Nausea: feeling of queasiness, sometimes with vomiting.
• Sweating: excessive perspiration, especially at night.
• Dry mouth: reduced salivation causing throat discomfort.
• Weight gain: increased appetite and fluid retention.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that can be life‑threatening.
• QT interval prolongation: cardiac rhythm disturbance that may cause arrhythmia.
• Seizures: occasional convulsive episodes.
• Severe hypotension: sudden drop in blood pressure.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Adrenal insufficiency: reduced cortisol production leading to fatigue and weakness.

Methadone Hydrochloride requires careful monitoring due to its potency and pharmacologic profile.

• Cardiac assessment: evaluate QT interval before initiating therapy.
• Respiratory monitoring: watch for signs of respiratory depression, especially during dose changes.
• Liver function: check hepatic enzymes regularly as metabolism is hepatic.
• Pregnancy safety: use only if benefits outweigh risks; discuss with obstetric provider.
• Renal adjustment: consider dose modification in severe renal impairment.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Methadone Hydrochloride interacts with several drug classes; some combinations should be avoided while others need close monitoring.

Major Interactions (Avoid)

• Benzodiazepines: additive CNS depression and increased risk of respiratory failure.
• MAO inhibitors: risk of severe hypotension and serotonin syndrome.
• QT‑prolonging agents: heightened chance of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin): may lower methadone plasma levels.
• CYP3A4 inhibitors (e.g., erythromycin): may raise methadone concentrations.
• Antidepressants (SSRIs, SNRIs): potential for serotonin syndrome.
• Anticholinergics: may exacerbate constipation.
• NSAIDs: increased risk of gastrointestinal bleeding.